The Centre for Food Safety is urging the public not to consume 21 batches of infant formula, due to concerns of possible presence of Cereulide produced by Bacillus cereus in the individual raw materials.
Dr. Kwan Yat Wah, Photo source: FB
Dr. Kwan Yat Wah, the President of the Asian Society for Pediatric Infectious Diseases, stated that Bacillus cereus will produce toxins at high temperatures. If infants drink contaminated formula, they may suffer from vomiting or diarrhoea, leading to malnutrition. Moreover, in severe cases, dehydration may occur, which can be very dangerous to the infants. He urged parents to seek immediate medical attention if their children exhibit the above symptoms.
Dr. Kwan further reminded parents that spores of Bacillus cereus multiply most rapidly at approximately 30 to 40 degrees Celsius, producing toxins. Therefore, the correct practice for parents is to store the formula, which has been prepared but not immediately drunk, in the refrigerator at a temperature below 4 degrees Celsius and heat it before the infants' drinking.
Dr. Kwan urged parents to seek immediate medical attention if their children exhibit the above symptoms. Photo source: online image
InvestHK hosts Chinese Medicine Forum to drive global expansion of Chinese medicine
Invest Hong Kong (InvestHK) today (January 8) hosted the Chinese Medicine Forum, bringing together leaders from government, academia and industry for comprehensive discussions on research translations, clinical practices and standards development. The forum showcased Hong Kong's strengths in driving Chinese medicine (CM) enterprises' global expansion, attracting the participation of over 150 industry stakeholders.
With the launch of the Government's first Chinese Medicine Development Blueprint and the opening of Hong Kong's first Chinese medicine hospital, the industry's focus on modernisation and international development of CM continues to grow. InvestHK hosted the forum to spark discussions on CM and actively attract and support CM enterprises to develop in Hong Kong, through providing one-stop support services to assist companies' expansion to overseas markets, achieve international certifications, and establish regional headquarters.
The Director-General of Investment Promotion of InvestHK, Ms Alpha Lau, said, "As highlighted in the 2025 Policy Address, the Government is committed to advancing the development of CM. Hong Kong's advantages lie in its ability to leverage the Chinese Mainland's robust CM capabilities while possessing internationalised systems and standards. With the advantages of 'one country, two systems', Hong Kong is committed to becoming the 'super platform' linking CM enterprises between the Chinese Mainland and the world. InvestHK will assist the industry in accessing global capital and markets, positioning Hong Kong as a springboard for CM to go global."
The Chinese Medicine Development Blueprint covers service enhancements, professional training, standards development, research translation and international co-operation, providing a systematic framework for high-quality development. The Commissioner for Chinese Medicine Development of the Health Bureau, Dr Vincent Chung, said, "The Blueprint is Hong Kong's first comprehensive policy document in this area, offering a clear direction for the high-quality development of CM. The Government will work closely with the industry to build Hong Kong into a bridgehead for CM to go global."
As the flagship institution, The Chinese Medicine Hospital of Hong Kong is actively driving clinical, research, and teaching initiatives. It is driving partnerships with international institutions to develop Hong Kong's integrated Chinese-Western medicine model into a global reference. The Hospital Chief Executive of The Chinese Medicine Hospital of Hong Kong, Professor Bian Zhaoxiang, stated, "Our hospital will fully support the Government in implementing the Chinese Medicine Development Blueprint, taking on the role of both flagship and 'change driver'. By specialising in disciplines and strengthening treatment of specific diseases, we will gather top talent to provide personalised services. At the same time, we will enhance the 'Hong Kong model' of collaboration between Chinese and Western medicine, developing high-standard clinical and research prototypes to set industry benchmarks. We will make good use of Hong Kong's international gateway advantages, and have already established strategic partnerships with institutions such as Chinese medicine hospitals on the Chinese Mainland, TCM-Klinik Bad Kötzting in Germany and Western Sydney University in Australia. Together, we will promote training, applications, and the development of Chinese patent medicines, supporting the high-quality growth of Chinese medicine in Hong Kong, the Greater Bay Area, and internationally to bring it to the world."
Hong Kong will accelerate its contribution to the internationalisation of CM standards. The Government Chinese Medicines Testing Institute combines local and national expertise and works with international specialists to set standards for Chinese medicinal materials, actively participating in the development of global technical platforms. The Assistant Director of Health (Chinese Medicine), Dr Edmund Fong, said, "Hong Kong will continue to contribute to the international application of CM standards and testing technologies. The Government Chinese Medicines Testing Institute under the Department of Health has already established internationally recognised reference standards for 357 Chinese materia medica, and will continue to strengthen exchanges and collaborations with testing institutions both locally and globally. To establish Hong Kong as a bridgehead for CM to go global, we will continue to actively participate in international herbal medicines platforms and, through our role as a World Health Organization Collaborating Centre for Traditional Medicine, make greater contributions to the global development of CM."
The General Manager of the Guangzhou Pharmaceutical Baiyunshan Hong Kong Company Limited, Mr Bruce Chan, added, "The Blueprint offers clear development pathways and new opportunities for internationalisation. Hong Kong's financial and innovation advantages make it a key platform for CM enterprises to expand globally. We look forward to deepening collaboration with local financial institutions, universities and research bodies to support the development of The Chinese Medicine Hospital of Hong Kong and the Government Chinese Medicines Testing Institute."
The Chinese Medicine Forum featured two panel discussions focusing on "Research and Clinical Practice in CM" and "Modernisation and Internationalisation of CM", in which speakers explored how research outcomes can be translated into clinical applications, the role of CM in modern healthcare systems, and strategies for setting international standards and promoting global certifications. Industry representatives shared practical experiences in achieving international certifications such as Good Manufacturing Practice (GMP) and International Organization for Standardization (ISO), and discussed strategies for cultural exchanges, standard promotion, and dissemination of clinical model to global. Following the forum, participants visited The Chinese Medicine Hospital of Hong Kong in Tseung Kwan O and toured the Northern Metropolis to explore opportunities presented by Hong Kong's development in CM.
Photo
InvestHK hosts Chinese Medicine Forum to drive global expansion of Chinese medicine Source: HKSAR Government Press Releases
InvestHK hosts Chinese Medicine Forum to drive global expansion of Chinese medicine Source: HKSAR Government Press Releases
InvestHK hosts Chinese Medicine Forum to drive global expansion of Chinese medicine Source: HKSAR Government Press Releases
InvestHK hosts Chinese Medicine Forum to drive global expansion of Chinese medicine Source: HKSAR Government Press Releases
InvestHK hosts Chinese Medicine Forum to drive global expansion of Chinese medicine Source: HKSAR Government Press Releases
InvestHK hosts Chinese Medicine Forum to drive global expansion of Chinese medicine Source: HKSAR Government Press Releases
InvestHK hosts Chinese Medicine Forum to drive global expansion of Chinese medicine Source: HKSAR Government Press Releases
InvestHK hosts Chinese Medicine Forum to drive global expansion of Chinese medicine Source: HKSAR Government Press Releases
InvestHK hosts Chinese Medicine Forum to drive global expansion of Chinese medicine Source: HKSAR Government Press Releases
